Skip to main content

Table 1 Demographic characteristics of the seven study patients

From: Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation

Patient Age (years) Weight (kg) Height (cm) SAPS II score Urine output (ml/24 hours)a Residual glomerular filtration rate (ml/min)b
1 65 76 170 42 300 <1
2 43 70 195 46 50 <1
3 51 76 165 28 1,650 5
4 71 89 178 64 0 0
5 46 61 183 65 150 <1
6 68 83 168 63 300 <1
7 68 88 163 64 100 <1
  1. aMean daily urine output during time of pharmacokinetic sampling. bCreatinine clearance measured at the inclusion; if necessary, continuous venovenous haemodiafiltration was stopped before enrollment to assess creatinine clearance. SAPS, Simplified Acute Physiologic Score.